Back to Peptides
RecoveryLow Risk

DSIP

Also known as: Delta Sleep-Inducing Peptide, Delta Sleep Peptide

Half-life:
30–60 minutes

Administration Routes

subcutaneousintranasal
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

Neuropeptide that modulates sleep architecture by promoting delta-wave sleep patterns. Reduces stress hormones including ACTH and cortisol, and interacts with hypothalamic-pituitary pathways to support recovery and circadian regulation.

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide studied for its role in sleep regulation and stress hormone modulation. It is used in research contexts to support sleep quality and recovery. For educational purposes only — consult a qualified healthcare provider.

Primary Research Areas

  • sleep quality
  • stress reduction
  • recovery
  • cortisol regulation

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Consult a healthcare professional before use.

Regulatory Status

Research OnlyNot Evaluated by FDA

Endogenous neuropeptide discovered 1977. Studied for sleep disorders but no FDA approval, no NDA or IND. Not on 503A bulks list. Sold as research chemical only.

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Research Stacks

Browse all stacks →

Where to Find DSIP